Compare J M Smucker Co (SJM) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J M Smucker Co vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? J M Smucker Co trades at $120.56 (market cap $12.38B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.24 (market cap $2.28B). The key difference: J M Smucker Co is far larger — about 5.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and J M Smucker Co pays a 3.86% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SJM | SLS | |
|---|---|---|
Market Cap | $12.38B | $2.28B |
Volume | 1,013,558 | 3,128,960 |
Sector | Consumer Staples | Health |
52-Week High | $132.34 | $15.46 |
52-Week Low | $89.53 | $1.39 |
Typical Hold Time | 74 Days | — |
Enterprise Value | $19.24B | $2.15B |
Dividend Yield | 3.86% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SJM trades at $119.41, up 2.23% today, with a bearish technical signal but strong recent earnings beats. The company reported a net loss of $1.23 billion in 2025 despite revenue growth to $8.73 billion, though analysts project a return to profitability in 2026. A dividend of $1.12 is scheduled for September 2026, and institutional interest is rising, as seen with CalSTRS increasing its stake significantly in Q2 2026.
The outlook is mixed: analyst consensus is bullish with a $137.29 price target, but high debt and volatile profitability pose risks. Earnings momentum from recent beats and raised 2027 guidance support upside, yet investors must weigh margin pressures and competitive threats in the consumer staples sector against growth in segments like Uncrustables and Cafe Bustelo.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
